Successful scale-up and scale out is essential when bringing advanced therapies to market. It is critical to create a reproducible, reliable, and predictable scale-up strategy, while preserving the integrity of the culture, moving efficiently, and keeping costs low.
Corning’s adherent and suspension expansion platforms streamline your production-level scale-up, without sacrificing yield, quality, or viability.